Jay Shepard

Companies

• Ironwood PharmaceuticalsBoard member Dec 3, 2020 to now¹
• Inovio PharmaceuticalsBoard member Jan 16, 2020 to now²
• Esperion TherapeuticsBoard member May 29, 2018 to now³
• Aravive, Inc.Board member Mar 20, 2014 to Jan 9, 2020⁴
• Aravive, Inc.Chief executive officer May 13, 2015 to Dec 26, 2019⁵
• Aravive, Inc.President May 13, 2015 to Dec 26, 2019⁵
• Marinus Pharmaceuticals (United States)Board member Jul 31, 2014 to Jan 19, 2017⁶
• DURECT CORPBoard member Sep 30, 2013 to Jun 23, 2016⁷

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• IPIronwood Pharmaceuticals IRWD235,036 shares⁸$828.5K at $3.52Jun 16, 2026
• Inovio Pharmaceuticals INO9,209 shares⁹$9.2K at $1.00May 21, 2025
• ETEsperion Therapeutics ESPR0 shares¹⁰Jul 13, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

• Jul 13, 2026Returned to company 164,472 shares of Esperion Therapeutics¹⁰
• Jun 16, 2026Granted 63,481 shares of Ironwood Pharmaceuticals⁸
• May 28, 2026Granted 79,873 shares of Esperion Therapeutics¹¹
• Jun 10, 2025Granted 45,000 shares of Ironwood Pharmaceuticals¹²
• May 29, 2025Granted 33,000 shares of Esperion Therapeutics¹³
• May 21, 2025Exercised options 2,167 shares of Inovio Pharmaceuticals⁹
• Jun 18, 2024Granted 24,311 shares of Ironwood Pharmaceuticals¹⁴
• May 23, 2024Granted 23,000 shares of Esperion Therapeutics¹⁵
• May 15, 2024Exercised options 2,166 shares of Inovio Pharmaceuticals¹⁶
• Jun 20, 2023Granted 22,350 shares of Ironwood Pharmaceuticals¹⁷
• Jun 15, 2023Granted 5,150 shares of Esperion Therapeutics¹⁸
• May 16, 2023Exercised options 19,000 shares of Inovio Pharmaceuticals¹⁹
• Jan 15, 2023Exercised options 4,273 shares of Inovio Pharmaceuticals²⁰
• Jun 1, 2022Granted 21,571 shares of Ironwood Pharmaceuticals²¹
• May 13, 2022Exercised options 18,000 shares of Inovio Pharmaceuticals²²
• Jan 15, 2022Exercised options 4,274 shares of Inovio Pharmaceuticals²³